Opening all blocked arteries with stents in patients with a heart attack, known as complete revascularization, reduces the ...

New research found a simplified clot-preventing medication regimen following stent placement in adults with atrial ...

One year of dual antiplatelet therapy with one of two potent P2Y12 inhibitors—ticagrelor or prasugrel—in people with Type 1 ...

Coronary artery disease (CAD) is the most prevalent form of heart disease, affecting approximately 18 million adults in the ...

Personalized vitamin D supplementation -- often requiring 5,000 IU of vitamin D each day -- did prove to have secondary ...

India’s new generation heart stent has received major global recognition for its innovation and effectiveness, showcasing the country’s leadership in advanced cardiac care and medical technology.

At the recent European Society of Cardiology Congress 2005, I had the honor of co-chairing, with my colleague Prof. Gitt, a fascinating session on stent thrombosis and drug-eluting stents (DES). As we ...

A significant Indian study reveals HIV-positive individuals face elevated cardiovascular risks, even with advanced treatments ...

NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single ...

Rapid treatment with CeleCor Therapeutics' investigational heart-attack drug, zalunfiban, resulted in higher levels of blood flow to the heart and an approximately 21% reduction in a patient's risk of ...

Amgen's Repatha lowered first heart attacks and strokes by 36% in a major trial, suggesting PCSK9 drugs may prevent acute ...